{
    "Trade/Device Name(s)": [
        "Panther Fusion SARS-CoV-2/Flu A/B/RSV Assay"
    ],
    "Submitter Information": "Hologic, Inc.",
    "510(k) Number": "K222736",
    "Predicate Device Reference 510(k) Number(s)": [
        "DEN200031"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "QOF",
        "OOI"
    ],
    "Summary Letter Date": "September 8, 2022",
    "Summary Letter Received Date": "September 9, 2022",
    "Submission Date": "May 15, 2023",
    "Regulation Number(s)": [
        "21 CFR 866.3981"
    ],
    "Regulation Name(s)": [
        "Device To Detect And Identify Nucleic Acid Targets In Respiratory Specimens From Microbial Agents That Cause The SARS-Cov-2 Respiratory Infection And Other Microbial Agents When In A Multi-Target Test"
    ],
    "Analyte Class(es)": [
        "virology",
        "microbiology"
    ],
    "Analyte(s)": [
        "SARS-CoV-2",
        "Influenza A virus",
        "Influenza B virus",
        "Respiratory Syncytial Virus (RSV)"
    ],
    "Specimen Type(s)": [
        "Nasopharyngeal (NP) swab specimens"
    ],
    "Specimen Container(s)": [
        "Hologic RespDirect Collection Kit",
        "UTM (Universal Transport Medium)",
        "VTM (Viral Transport Medium)"
    ],
    "Instrument(s)/Platform(s)": [
        "Panther Fusion system"
    ],
    "Method(s)/Technology(ies)": [
        "Multiplex real-time reverse transcriptase PCR (RT-PCR)",
        "Automated nucleic acid amplification",
        "Fluorescent detection"
    ],
    "Methodologies": [
        "RT-PCR",
        "Multiplex PCR",
        "Nucleic acid extraction and amplification"
    ],
    "Submission Type(s)": [
        "Assay",
        "Reagent",
        "Collection device"
    ],
    "Document Summary": "FDA 510(k) summary for Panther Fusion SARS-CoV-2/Flu A/B/RSV multiplex RT-PCR assay for detection and differentiation of respiratory viruses using the Panther Fusion system",
    "Indications for Use Summary": "Qualitative detection and differentiation of SARS-CoV-2, influenza A, influenza B, and RSV nucleic acids from nasopharyngeal swab specimens in symptomatic individuals to aid differential diagnosis of respiratory infections using the Panther Fusion system",
    "fda_folder": "Microbiology"
}